J M Olefsky Selected Research

J M Olefsky Research Topics

10	Insulin Resistance 07/2015 - 01/2000
2	Obesity 07/2015 - 04/2000
2	Neoplasms (Cancer) 07/2015 - 04/2000
2	Shock 12/2000 - 09/2000
2	Type 2 Diabetes Mellitus (MODY) 04/2000 - 01/2000
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Inflammation (Inflammations) 07/2015
1	Kidney Diseases (Kidney Disease) 02/2001
1	Diabetes Mellitus 02/2001
1	Diabetes Complications 02/2001
1	Hyperglycemia 01/2001
1	Atherosclerosis 04/2000
1	Body Weight (Weight, Body) 02/2000

7	Glucose (Dextrose)FDA LinkGeneric 06/2001 - 01/2000
6	Insulin (Novolin)FDA Link 12/2000 - 01/2000
3	PPAR gammaIBA 11/2000 - 02/2000
2	Proteins (Proteins, Gene)FDA Link 06/2000 - 04/2000
2	Troglitazone (Rezulin)FDA Link 04/2000 - 01/2000
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2015
1	Fish OilsIBA 07/2015
1	JNK Mitogen-Activated Protein KinasesIBA 07/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2001
1	Nonesterified Fatty Acids (NEFA)IBA 06/2001
1	Glucosamine (Dona)IBA 01/2001
1	HexosaminesIBA 01/2001
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2000
1	Tyrosine (L-Tyrosine)FDA Link 12/2000
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2000
1	GenisteinIBA 09/2000
1	Tyrosine Kinase InhibitorsIBA 09/2000
1	Insulin ReceptorIBA 06/2000
1	Insulin Receptor Substrate ProteinsIBA 06/2000
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2000
1	TensinsIBA 04/2000
1	Protein Tyrosine PhosphatasesIBA 04/2000
1	Plasminogen Activator Inhibitor 1IBA 04/2000
1	AntigensIBA 04/2000
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2000
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2000

1	Surgical Amputation (Amputations) 02/2001